Current Report No: 10/2025
Date: June 13, 2025
Legal Basis: Article 56 (1) (2) of the act on Public Offering – Current and Periodic Information
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“) hereby informs that on June 13, 2025, the Company received from the shareholder – Biofund Capital Management LLC (“BioFund“) a submission of draft resolutions concerning matters included in the agenda of the Ordinary General Meeting of the Company, which was convened for June 17, 2025, at 2:00 p.m., i.e. the notification:
- to item 13 of the agenda, which provides for the adoption of a resolution on determining the number of members of the Supervisory Board for the next term of office, and
- to item 14 of the agenda, which provides for the adoption of resolutions on the appointment of members of the Supervisory Board for the next term of office, together with the nomination of Mr. Michał Żótłowski as Chairman of the Supervisory Board of the Company in the election of members of the Supervisory Board at the Ordinary General Meeting of the Company convened for June 17, 2025.
In accordance with the justification for the shareholder’s request, the agenda of the Ordinary General Meeting included an item concerning the determination of the number of members of the Supervisory Board for the next term of office and an item concerning the adoption of resolutions on the appointment of members of the Supervisory Board for the next term of office. The proposed draft resolutions are in line with the agenda introduced by the Management Board. The advance submission by BioFund of the candidacy of Mr. Michał Żółtowski for the Chairperson of the Supervisory Board of the Company is also in line with good market practices.
The shareholder’s request was accompanied by draft resolutions, the candidate’s resume (BIO) and a statement of consent to stand as a candidate and appoint Mr. Michał Żółtowski to the Supervisory Board of the Company. The draft resolutions on the matters included in the agenda and the candidate’s resume (BIO) submitted by the shareholder are attached to the report.
Detailed Legal Basis: § 19(1)(4) of the Regulation of the Minister of Finance of March 29, 2018, on current and periodic information provided by issuers of securities and the conditions for recognizing information required by the laws of a non-member state as equivalent.